Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT VIII Kids: BAY94-9027 in Pediatric Hemophilia A
NCT01775618Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2013
- Primary completion
- Mar 2015
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of damoctocog alfa pegol in hemophilia A, sponsored by Bayer. Started May 2013; status: completed.
02
Drugs
damoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01775618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01775618.